Clinical Trial Update: Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating long-term effects of imiquimod and diclofenac in actinic keratoses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Diclofenac (diclofenac)
• Imiquimod (imiquimod)

Snippet

Sponsor: MEDA Pharma GmbH & Co. KG | Conditions: Actinic Keratosis | Phase 4 | Status: COMPLETED